Human African trypanosomiasis in a rural community, Democratic Republic of Congo

Emerging Infectious Diseases

Volumn 13, Issue 2, 2007, Pages 248-254

  Lutumba, Pascal ^a,b   Makieya, Eric ^c   Shaw, Alexandra ^d   Meheus, Filip ^e   Boelaert, Marleen ^b  

^a Programme National de Lutte Contre la Trypanosomiase Humaine Africaine   (Congo)

^b INSTITUTE OF TROPICAL MEDICINE   (Belgium)

^c UNIVERSITY OF KINSHASA   (Congo)

^d AP Consultants   (United Kingdom)

^e ROYAL TROPICAL INSTITUTE   (Netherlands)

Author keywords

[No Author keywords available]

Indexed keywords

ADULT; AFRICAN TRYPANOSOMIASIS; AGED; ARTICLE; CHILD; CONGO; CONTROLLED STUDY; COST EFFECTIVENESS ANALYSIS; FEMALE; HUMAN; MAJOR CLINICAL STUDY; MALE; QUALITY ADJUSTED LIFE YEAR; QUESTIONNAIRE; RURAL POPULATION; WORLD HEALTH ORGANIZATION;

EID: 33846697946     PISSN: 10806040     EISSN: 10806059     Source Type: Journal    
DOI: 10.3201/eid1302.060075     Document Type: Article

References (25)

1. World Health Organization. Human African trypanosomiasis (sleeping sickness): epidemiological update. Wkly Epidemiol Rec. 2006;81:71-80.
2. Odiit M, Coleman PG, Liu WC, McDermott JJ, Fèvre EM, Welburn SC, et al. Quantifying the level of under-detection of Trypanosoma brucei rhodesiense sleeping sickness cases. Trop Med Int Health. 2005;10:840-9.
3. Lyons M. The colonial disease. Asocial history of sleeping sickness in northern Zaire, 1900-1940, Cambridge (UK): Cambridge University Press; 1992.
4. Lutumba P, Robays J, Miaka C, Kande V, Molisho D, Declercq J, et al. Trypanosomiasis control, Democratic Republic of Congo, 1993-2003. Emerg Infect Dis. 2005;11:1382-8.
5. Murray CJL. Quantifying the burden of disease: the technical basis for disability-adjusted life years. Bull World Health Organ. 1994;72:429-45.
6. World Bank. World development report 1993: investing in health. Washington: The Bank; 1993.
7. World Health Organization. The world health report 2004. Geneva: The Organization; 2004.
8. Arnesen T, Nord E. The value of DALY life: problems with ethics and validity of disability adjusted life years. BMJ. 1999;319:1423-5.
9. Cattand PP. Human African trypanosomiasis. The current epidemiologic situation, an alarming recrudescence of the disease. Bull Soc Pathol Exot. 1994;87:307-10.
10. Russell S. The economic burden of illness for households in developing countries: a review of studies focusing on malaria, tuberculosis, and human immunodeficiency virus/acquired immunodeficiency syndrome. Am J Trop Med Hyg. 2004;71:147-55.
11. Gouteux JP, Bansimba P, Noireau F, Frézil JL. Cost of the individual treatment of Trypanosoma brucei gambiense trypanosomiasis in a focus of infection in Niari (Congo) [in French]. Med Trop (Mars). 1987;47:61-3.
12. Robays J, Miaka MM, Van der Stuyft P, Boelaert M. The effectiveness of active population screening and treatment for sleeping sickness control in the Democratic Republic of Congo. Trop Med Int Health. 2004;9:542-50.
13. Robays J, Lefèvre P, Lutumba P, Lubanza S, Kande Betu Ku Mesu V, Van der Stuyft P, et al. Drug toxicity and cost as barriers to community participation in HAT control in the Democratic Republic of Congo. Trop Med Int Health. 2006. In press.
14. Kapiriri L, Norheim OF, Heggenhougen K. Using burden of disease information for health planning in developing countries: the experience from Uganda. Soc Sci Med. 2003;56:2433-41.
15. Chandramohan D, Maude GH, Rodrigues LC, Hayes RJ. Verbal autopsies for adult deaths: their development and validation in a multicentre study. Trop Med Int Health. 1998;3:436-46.
16. Fox-Rushby JA, Hanson K. Calculating and presenting disability adjusted life years (DALYs) in cost-effectiveness analysis. Health Policy Plan. 2001;16:326-31.
17. Lutumba P, Robays J, Miaka C, Kande V, Simarro PP, Shaw AP, et al. The efficiency of different detection strategies of human African trypanosomiasis by T. b. gambiense [in French]. Trop Med Int Health. 2005;10:347-56.
18. Fèvre EM, Coleman PG, Welburn SC, Maudlin I. Reanalyzing the 1900-1920 sleeping sickness epidemic in Uganda. Emerg Infect Dis. 2004;10:567-73.
19. Odiit M, Shaw A, Welburn SC, Fèvre EM, Coleman PG, McDermott JJ. Assessing the patterns of health-seeking behaviour and awareness among sleeping-sickness patients in eastern Uganda. Ann Trop Med Parasitol. 2004;98:339-48.
20. Guyatt HL, Ochola SA, Snow RW. Too poor to pay: charging for insecticide-treated bed nets in highland Kenya. Trop Med Int Health. 2002;7:846-50.
21. Ettling M, McFarland DA, Schultz LS, Chitsulo L. Economic impact of malaria in Malawian households. Trop Med Parasitol. 1994;45:74-9.
22. Wyss K, Kilima P, Lorenz N. Cost of tuberculosis for households and health care providers in Dar es Salaam, Tanzania. Trop Med Int Health. 2001;6:60-8.
23. Shaw AP, Cattand P. Analytical tools for planning cost-effective surveillance in Gambiense sleeping sickness. Med Trop (Mars). 2001;61:412-21.
24. Goodman CA, Coleman PG, Mills AJ. Cost-effectiveness of malaria control in sub-Saharan Africa. Lancet. 1999;354:378-85.
25. Jamison DT, Mosley WH, Measham AR, Bobadilla JL. Disease control priorities in developing countries. New York: Oxford University Press; 1993.